Suscribirse

Visualization of Coronary Artery Calcification: Influence on Risk Modification - 31/08/15

Doi : 10.1016/j.amjmed.2015.03.033 
Rikke E. Mols, RN, MSc a, Jesper M. Jensen, MD, PhD b, Niels Peter Sand, MD, PhD c, Charlotte Fuglesang, RN, MPH b, Døne Bagdat, RN c, Peter Vedsted, MD, PhD d, Hans Erik Bøtker, MD, DMSc b, Lene H. Nielsen, MD a, Bjarne L. Nørgaard, MD, PhD b,
a Department of Cardiology, Lillebaelt Hospital-Vejle, Vejle, Denmark 
b Department of Cardiology, Aarhus University Hospital-Skejby, Aarhus, Denmark 
c Department of Cardiology, Hospital of South West Denmark-Esbjerg and The Regional Unit of Health Research, University of Southern Denmark, Esbjerg, Denmark 
d Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark 

Requests for reprints should be addressed to Bjarne Linde Nørgaard, MD, PhD, Department of Cardiology, Aarhus University Hospital-Skejby, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus N, Denmark.

Abstract

Objectives

Direct health provider to patient presentation of coronary computed tomography angiography findings may increase adherence to preventive therapy and risk modification. The purpose of this study was to assess the influence of visualization of coronary artery calcification and lifestyle recommendations on cholesterol concentrations and other risk variables in symptomatic patients with nonobstructive coronary artery disease and hyperlipidemia.

Methods

We performed a prospective 2-center randomized controlled trial. Patients were randomized 1:1 to intervention or standard follow-up in general practice. The primary end point was change in plasma total cholesterol concentration at 6 months follow-up.

Results

We included 189 patients (mean [± standard deviation] age 61 [12] years, 57% were male). Median (range) Agatston score was 166 (70-2054). The reduction in plasma total cholesterol concentrations tended to be higher in the intervention group than in the control group, 51.04 mg/dL versus 45.63 mg/dL (P = .181). In a subgroup including patients continuing statin therapy during follow-up (n = 147), the reduction in plasma total cholesterol concentrations was more pronounced in the intervention group than in the control group, 66.13 mg/dL versus 55.68 mg/dL (P = .027). In the intervention group, there was a higher degree of statin adherence and a higher proportion of patients who stopped smoking and commenced healthier dietary behavior than in the control group.

Conclusions

Visualization of coronary artery calcification and brief recommendations about risk modification after coronary computed tomography angiography in symptomatic patients with nonobstructive coronary artery disease and hyperlipidemia may have a favorable influence on plasma total cholesterol concentration, adherence to statin therapy, and risk behavior. Further investigations are needed.

El texto completo de este artículo está disponible en PDF.

Keywords : Adherence preventive therapy, Angina pectoris, Atherosclerosis, Coronary artery calcification, Lifestyle behavior, Risk factor modification


Esquema


 Funding: This study received financial support from the Lillebaelt Hospital-Vejle Research Foundation (U-08-01), Novo Nordisk Foundation (1-01-5087), and TRYG Foundation (7-12-0441).
 Conflict of Interest: None.
 Authorship: All authors had access to the data and played a role in writing this manuscript.


© 2015  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 128 - N° 9

P. 1023.e23-1023.e31 - septembre 2015 Regresar al número
Artículo precedente Artículo precedente
  • Serum Albumin and Prealbumin in Calorically Restricted, Nondiseased Individuals: A Systematic Review
  • Jessica L. Lee, Esther S. Oh, Rebecca W. Lee, Thomas E. Finucane
| Artículo siguiente Artículo siguiente
  • Restless Legs Syndrome and Cognitive Function: A Population-based Cross-sectional Study
  • Pamela M. Rist, Alexis Elbaz, Carole Dufouil, Christophe Tzourio, Tobias Kurth

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.